MB Pharma project develops DUOFAG and TRIOFAG phage medicines and GMP pilot production

MB Pharma describes a publicly funded project to develop and clinically test DUOFAG for post-surgical wound infections and TRIOFAG for respiratory infections, with two functional product samples and two pilot production lines as planned outputs. The project page identifies the Czech Ministry of Industry and Trade and the Deep Tech call; it does not state a publication or project-start date.